Other Events ·
Nano-X seeks shareholder approval for reverse split framework and share capital increase
NNOXNano-X Imaging Ltd.
Nano-X Imaging Ltd. has filed a proxy statement for a special general meeting on November 18, 2026, to vote on two proposals. First, shareholders will approve an amendment to the articles of association to increase authorized share capital by NIS 3,000,000 (300 million shares), raising total authorization to 450 million shares. Second, shareholders will approve a framework allowing the board to effect a reverse split at a ratio between 1-for-20 and 1-for-50 within 18 months. The company cites Nasdaq’s $1.00 minimum bid price non-compliance notification received on September 28, 2026, as the primary driver for the split framework to avoid potential delisting by March 29, 2027. Nano-X Imaging Ltd. operates in the healthcare imaging and health information technology industries.